Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies

@article{Obermiller1999GeneTF,
  title={Gene therapy for carcinoma of the breast: Therapeutic genetic		  correction strategies},
  author={Patrice S. Obermiller and David L. Tait and Jeffrey T. Holt},
  journal={Breast Cancer Research},
  year={1999},
  volume={2},
  pages={28 - 31}
}
Gene therapy is a therapeutic approach that is designed to correct specific molecular defects that contribute to the cause or progression of cancer. Genes that are mutated or deleted in cancers include the cancer susceptibility genes p53 and BRCA1. Because mutational inactivation of gene function is specific to tumor cells in these settings, cancer gene correction strategies may provide an opportunity for selective targeting without significant toxicity for normal nontumor cells. Both p53 and… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 49 references

Current status of gene therapy for ovarian cancer

DL Tait, H Jones, JT Holt
CME J Gynecol Oncol • 2000

BRCA1-associated growth arrest is RB-dependent.

Proceedings of the National Academy of Sciences of the United States of America • 1999
View 1 Excerpt

Localization of human BRCA 1 and its loss in high - grade , noninherited breast carcino

K Yoshikawa, K Honda, T Inamoto
Nature Genet • 1999

Similar Papers

Loading similar papers…